Hans-Peter Buchstaller
6PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Dec 22, 2023
AIDDISON: Empowering Drug Discovery with AI/ML and CADD Tools in a Secure, Web-Based SaaS Platform.Andrew Rusinko, Mohammad Rezaei, Lukas Friedrich
|Jul 05, 2023
Discovery of Cycloalkyl[c]thiophenes as Novel Scaffolds for Hypoxia-Inducible Factor-2α Inhibitors.Hans-Peter Buchstaller, Ada Sala-Hojman, Matthias Leiendecker
|Feb 02, 2023
Identification of M4205─A Highly Selective Inhibitor of KIT Mutations for Treatment of Unresectable Metastatic or Recurrent Gastrointestinal Stromal Tumors.Andreas Blum, Dieter Dorsch, Nina Linde
|Jul 13, 2021
Optimization of a Screening Hit toward M2912, an Oral Tankyrase Inhibitor with Antitumor Activity in Colorectal Cancer Models.Hans-Peter Buchstaller, Uwe Anlauf, Dieter Dorsch
|Aug 20, 2020
Large-Scale Assessment of Binding Free Energy Calculations in Active Drug Discovery Projects.Christina E M Schindler, Hannah Baumann, Andreas Blum
|Aug 06, 2019
Discovery and Optimization of 2-Arylquinazolin-4-ones into a Potent and Selective Tankyrase Inhibitor Modulating Wnt Pathway Activity.Hans-Peter Buchstaller, Uwe Anlauf, Dieter Dorsch
Pageof 1
